Provectus Biopharmaceuticals PVCT
OTC PVCT
$0.05 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Provectus Biopharmaceuticals (PVCT) Other financing activities (2025)

Updated

Provectus Biopharmaceuticals' Other financing activities came in at $711,470 for FY2017, unchanged from $711,470 in FY2016.

Analysis

Provectus Biopharmaceuticals (PVCT) Other financing activities (2025) Analysis & Trends

  • Per Business Quant, earlier years put Other financing activities at $711,470 in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Provectus Biopharmaceuticals 21.01 Mn 19.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 150,000.00
Mar 31, 2025 700,000.00
API Access

Provectus Biopharmaceuticals Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=PVCT&period=max&api_key=YOUR_API_KEY